Education
About Us
Working with TipRanks
Follow Us
Neuroscientific Biopharmaceuticals Ltd. (AU:NSB)
ASX:NSB
Total Valuation
Neuroscientific Biopharmaceuticals Ltd. has a market cap or net worth of AU$49.89M. The enterprise value is AU$5.54M.
Market CapAU$49.89M
Enterprise ValueAU$5.54M
Share Statistics
Neuroscientific Biopharmaceuticals Ltd. has 332,575,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding332,575,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Neuroscientific Biopharmaceuticals Ltd.’s return on equity (ROE) is -0.11 and return on invested capital (ROIC) is -11.40%.
Return on Equity (ROE)-0.11
Return on Assets (ROA)-0.11
Return on Invested Capital (ROIC)-11.40%
Return on Capital Employed (ROCE)-0.11
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Neuroscientific Biopharmaceuticals Ltd. is 21.3. Neuroscientific Biopharmaceuticals Ltd.’s PEG ratio is 0.01.
PE Ratio21.3
PS Ratio0.00
PB Ratio0.76
Price to Fair Value0.76
Price to FCF-13.54
Price to Operating Cash Flow20.00
PEG Ratio0.01
Income Statement
In the last 12 months, Neuroscientific Biopharmaceuticals Ltd. had revenue of 0.00 and earned -1.85M in profits. Earnings per share was -0.01.
Revenue0.00
Gross Profit-92.78K
Operating Income-1.92M
Pretax Income-1.85M
Net Income-1.85M
EBITDA-1.92M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -941.33K and capital expenditures 0.00, giving a free cash flow of -941.33K billion.
Operating Cash Flow-941.33K
Free Cash Flow-941.33K
Free Cash Flow per Share>-0.01
Dividends & Yields
Neuroscientific Biopharmaceuticals Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.28
52-Week Price Change250.00%
50-Day Moving Average0.17
200-Day Moving Average0.10
Relative Strength Index (RSI)41.04
Average Volume (3m)306.60K
Important Dates
Neuroscientific Biopharmaceuticals Ltd. upcoming earnings date is Mar 4, 2026, TBA (Confirmed).
Last Earnings DateAug 28, 2025
Next Earnings DateMar 4, 2026
Ex-Dividend Date―
Financial Position
Neuroscientific Biopharmaceuticals Ltd. as a current ratio of 49.56, with Debt / Equity ratio of 0.00%
Current Ratio49.56
Quick Ratio49.56
Debt to Market Cap0.00
Net Debt to EBITDA3.79
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Neuroscientific Biopharmaceuticals Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Neuroscientific Biopharmaceuticals Ltd. EV to EBITDA ratio is -2.86, with an EV/FCF ratio of -5.82.
EV to Sales0.00
EV to EBITDA-2.86
EV to Free Cash Flow-5.82
EV to Operating Cash Flow-5.82
Balance Sheet
Neuroscientific Biopharmaceuticals Ltd. has AU$7.27M in cash and marketable securities with AU$0.00 in debt, giving a net cash position of AU$7.27M billion.
Cash & Marketable SecuritiesAU$7.27M
Total DebtAU$0.00
Net CashAU$7.27M
Net Cash Per ShareAU$0.02
Tangible Book Value Per ShareAU$0.05
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Neuroscientific Biopharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-672.73%